HK1175780A1 - Crystalline cdc7 inhibitor salts cdc7 - Google Patents

Crystalline cdc7 inhibitor salts cdc7

Info

Publication number
HK1175780A1
HK1175780A1 HK13103038.3A HK13103038A HK1175780A1 HK 1175780 A1 HK1175780 A1 HK 1175780A1 HK 13103038 A HK13103038 A HK 13103038A HK 1175780 A1 HK1175780 A1 HK 1175780A1
Authority
HK
Hong Kong
Prior art keywords
cdc7
crystalline
inhibitor salts
salts
inhibitor
Prior art date
Application number
HK13103038.3A
Other languages
English (en)
Chinese (zh)
Inventor
．贊姆皮裡
．瓦諾蒂
．西瓦羅裡
．弗納雷托
Original Assignee
內爾維阿諾醫學科學有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 內爾維阿諾醫學科學有限公司 filed Critical 內爾維阿諾醫學科學有限公司
Publication of HK1175780A1 publication Critical patent/HK1175780A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK13103038.3A 2009-11-11 2013-03-12 Crystalline cdc7 inhibitor salts cdc7 HK1175780A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09175648 2009-11-11
PCT/EP2010/066873 WO2011057960A1 (en) 2009-11-11 2010-11-05 Crystalline cdc7 inhibitor salts

Publications (1)

Publication Number Publication Date
HK1175780A1 true HK1175780A1 (en) 2013-07-12

Family

ID=43513935

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13103038.3A HK1175780A1 (en) 2009-11-11 2013-03-12 Crystalline cdc7 inhibitor salts cdc7

Country Status (9)

Country Link
US (1) US8658662B2 (de)
EP (1) EP2499128B1 (de)
JP (1) JP5856971B2 (de)
CN (1) CN102666528B (de)
AR (1) AR078960A1 (de)
ES (1) ES2543098T3 (de)
HK (1) HK1175780A1 (de)
TW (1) TW201125861A (de)
WO (1) WO2011057960A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013026137B1 (pt) * 2011-04-19 2020-12-01 Nerviano Medical Sciences S.R.L pirimidinil-pirróis substituídos ativos como inibidores da quinase
US8912200B2 (en) 2011-07-28 2014-12-16 Nerviano Medical Sciences S.R.L. Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202463D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
KR20090008286A (ko) 2006-03-27 2009-01-21 네르비아노 메디칼 사이언시스 에스.알.엘. 키나제 억제제로서의 피리딜- 및 피리미디닐-치환된 피롤-,티오펜- 및 푸란- 유도체
TWI426074B (zh) * 2008-04-30 2014-02-11 Nerviano Medical Sciences Srl ５－（２－胺基－嘧啶－４－基）－２－芳基－１ｈ－吡咯－３－羧醯胺之製造方法

Also Published As

Publication number Publication date
US20120245189A1 (en) 2012-09-27
TW201125861A (en) 2011-08-01
AR078960A1 (es) 2011-12-14
US8658662B2 (en) 2014-02-25
JP5856971B2 (ja) 2016-02-10
JP2013510811A (ja) 2013-03-28
CN102666528A (zh) 2012-09-12
EP2499128A1 (de) 2012-09-19
WO2011057960A1 (en) 2011-05-19
ES2543098T3 (es) 2015-08-14
CN102666528B (zh) 2014-04-16
EP2499128B1 (de) 2015-06-03

Similar Documents

Publication Publication Date Title
ZA201105462B (en) Crystalline insulin-conjugates
HK1179477A1 (en) Kinase inhibitors
HK1165425A1 (zh) 作為 抑制劑的 -環烷基氨基喹諾酮
ZA201203842B (en) Kinase inhibitors
EP2460798A4 (de) Apaf-1-hemmer-verbindungen
SI2299999T1 (sl) Stat3 inhibitorji
GB0819182D0 (en) Crystalline forms
ZA201108131B (en) Dihydroorotate- dehydrogenasee inhibitors as virostatic compounds
EP2558099A4 (de) Kinase-inhibitoren
HK1169408A1 (en) Cdk inhibitor salts cdk
ZA201100898B (en) Novel inhibitors
HK1195773A1 (zh) 抑制劑的鹽類
EP2519508A4 (de) Metalloenzymhemmerverbindungen
EP2413941A4 (de) Renin-inhibitoren
EP2421882A4 (de) Angiogenesehemmer
GB0901898D0 (en) Dual calpain-ros inhibitors
GB0907886D0 (en) Corrosion inhibitor
EP2496230A4 (de) Ire-1-alpha-hemmer
EP2467385A4 (de) Renin-inhibitoren
EP2480076A4 (de) Imidothiazolkinaseinhibitoren
ZA201102837B (en) Phosphodiestarase inhibitors
HK1175780A1 (en) Crystalline cdc7 inhibitor salts cdc7
IL213935A0 (en) Novel heterocyclic compounds as metap-2 inhibitors
GB0901900D0 (en) Dual calpain-ros inhibitors
GB0914726D0 (en) Kinase inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231107